PPT-Figure 1.1 Distribution of NHANES participants with diabetes, self-reported cardiovascular

Vol 1 CKD Ch 1 2 Data Source National Health and Nutrition Examination Survey NHANES 19881994 19992004 amp 20072012 participants aged 20 amp older Note Cardiovascular disease designation is based on selfreport of any CVD condition see CKD Analytical Methods chapter for detail CKD is defined as eGFR lt60 or ACR 30 Abbreviations ACR urine albumincreatinine ratio CKD chronic kidney disease SR CVD selfreported cardiovascular disease DM diabetes mellitus eGFR estimated glomerular filtration rate. Applying evidence based medicine to clinical care. Cardiovascular disease is the biggest killer in UK. Number. of . deaths. (000’s). 124,037. 60,666. 18,165. 33,634. 16,216. 12,762. 103,431. 19,996. Prevalence of Diabetes and Prediabetes in the United States. 2. 1. CDC. . National diabetes fact sheet, 2008. http://. www.cdc.gov/diabetes/pubs/pdf/ndfs_2008.pdf.. 2. CDC. National diabetes fact sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.. Worldwide Prevalence of Diabetes. 2. IDF. Diabetes Atlas Update 2015. Available at: http://www.idf.org/sites/default/files/Atlas7e-poster.pdf.. Current estimated prevalence: 415 million worldwide. By 20. National Heath And Nutrition Examination Survey (NHANES). 2007- 2010. Natalie E. Dupree M.S., . National Center for Health Statistics. NHANES Website Links. Survey Content Brochure. http://www.cdc.gov/nchs/data/nhanes/survey_content_99_10.pdf. 1 Table 1.1 Distribution of NHANES participants with diabetes, self-reported cardiovascular disease, & single sample markers of CKD, 2007-2012. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2005–2012 participants age 20 & older. Note: Cardiovascular disease designation is based on self-report of any CVD condition (see CKD Analytical Methods chapter for detail); CKD is defined as eGFR <60 or ACR ≥30. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; SR CVD, self-reported cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; . not applicable.. Deepak L. Bhatt, MD, MPH. Professor . of Medicine, Harvard Medical School. Executive Director of Interventional Cardiovascular Programs. Brigham & Women’s Hospital Heart and Vascular Center. Boston, Massachusetts. ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular disease Jane Armitage and Louise Bowman on behalf of the ASCEND Study Collaborative Serum creatinine is not standardized in maEducation Program is attempting to have all laboratories standardize serum creatinine to reference methods Myers GL Recommendations for Improving Serum Creat Antidiabetes. Medications:. Cardiovascular Benefits. Hengameh. . Abdi. Endocrine Research Center. Research Institute for Endocrine sciences. Shahid. . Beheshti. University of Medical Sciences. 13 December 2018. European Association for the Study of Diabetes. Lisbon, . 13. th. . September 2017. ISRCTN number: 91899513. ClinicalTrials.gov number: . NCT00829660. Study Rationale, Design and Conduct. The Diabetes Burden. David J Albrecht D.O.. Heart & Vascular 2018 Winter Conference. Cardiovascular risk . m. odification in relation to current diabetes management . therapies. Case study highlighting the therapeutic decisions . TECOS Executive Committee MemberRury R. Holman, MB, ChBDiabetes Trials Unit, OCDEM Churchill Hospital, Oxford, United KingdomTECOS CoPrincipal Investigator andJoint Chair of TECOS Executive CommitteeR Sex . Male. Diabetes. . History. T2D, . onset. @45 . yrs. , treatment: . metformin. , . sitagliptin. and . gliclazide. . Organ. . damage. . evaluation. :. Eyes. : No . signs. of . retinopathy. GGC MCN meeting 5. th. February 2019. John R Petrie. Professor of Diabetic Medicine. University of Glasgow, UK. Advisory and Consultancy Work:. Novo Nordisk, Sanofi-Aventis, Biocon, Astra Zeneca, . Servier.